Justification Redacted_Redacted.pdf

This is a Sole Source Justification and Approval (J&A) document from the Department of Veterans Affairs VISN 08 for a follow-on procurement of BioFire brand reagents for Molecular Pathogen Detection testing. The procurement, with Acquisition ID 36C248-24-AP-5743, covers a base year plus four option years from December 2024 through December 2029, with an estimated total value of $32,235,631.04.

The J&A establishes Biomerieux Inc. as the only source capable of providing the BioFire FilmArray Torch Diagnostics system and associated reagents required across seven VA medical facilities in Florida and Puerto Rico. The justification cites Biomerieux's proprietary FDA-approved testing panels that detect multiple pathogens including respiratory, blood culture, gastrointestinal, and meningitis/encephalitis panels. Market research, including an RFI posted on SAM.gov on 9/3/2024 and a Sources Sought notice, confirmed Biomerieux as the sole manufacturer and distributor. The document notes that using any other vendor would require purchasing new equipment and software, causing significant cost duplication and potential disruption to patient care. A previous sole source award to Biomerieux (36C25524D0003) was made by NCO 15 on 10/1/2023 for $13.6M over five years.